Geron Market Cap

Geron has a market cap or net worth of $904.42 million as of April 24, 2025. Its market cap has decreased by -51.71% in one year.

Market Cap

904.42M

Enterprise Value

525.05M

1-Year Change

-51.71%

Ranking

#2431

Market Cap Chart

Since December 1, 1998, Geron's market cap has increased from $159.40M to $904.42M, an increase of 467.39%. That is a compound annual growth rate of 6.79%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2025	904.40M	-57.74%
Dec 31, 2024	2.14B	86.74%
Dec 29, 2023	1.15B	24.20%
Dec 30, 2022	922.60M	134.88%
Dec 31, 2021	392.80M	-20.44%
Dec 31, 2020	493.70M	81.71%
Dec 31, 2019	271.70M	45.84%
Dec 31, 2018	186.30M	-35.00%
Dec 29, 2017	286.60M	-12.99%
Dec 30, 2016	329.40M	-56.99%
Dec 31, 2015	765.80M	49.89%
Dec 31, 2014	510.90M	-16.42%
Dec 31, 2013	611.30M	231.51%
Dec 31, 2012	184.40M	-5.24%
Dec 30, 2011	194.60M	-63.43%
Dec 31, 2010	532.20M	4.66%
Dec 31, 2009	508.50M	37.54%
Dec 31, 2008	369.70M	-13.62%
Dec 31, 2007	428.00M	-26.52%
Dec 29, 2006	582.50M	4.37%
Dec 30, 2005	558.10M	53.45%
Dec 31, 2004	363.70M	-6.72%
Dec 31, 2003	389.90M	337.60%
Dec 31, 2002	89.10M	-53.52%
Dec 31, 2001	191.70M	-42.86%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	733.66B
UnitedHealth Group	383.91B
Johnson & Johnson	376.68B
AbbVie	304.88B
Novo Nordisk	266.18B
Abbott Laboratories	226.19B
Novartis AG	209.93B
AstraZeneca	208.11B

Market Cap Rankings